Wednesday, April 28, 2021 1:18:50 PM
If India opens it to wider / faster use due to the current situation, especially if it has a compassion component and we start seeing more results, this should go A LOT higher.
The original runs last year were based on super speculative news. Now with results, the FDA looking at this seriously, AND the India trials (with potential to help more over their during a crisis)... this could be big.
Covid is not going away with vaccinations and the variants are lowering the efficacy of the current vaccines. They're already talking Boosters. There are spikes in Canada in locations (hospitals filling up again), Brazil, and a few other locations that would also benefit from this drug. Ultimately, it's to keep people alive and give them a better chance for future health.
The original runs last year were based on super speculative news. Now with results, the FDA looking at this seriously, AND the India trials (with potential to help more over their during a crisis)... this could be big.
Covid is not going away with vaccinations and the variants are lowering the efficacy of the current vaccines. They're already talking Boosters. There are spikes in Canada in locations (hospitals filling up again), Brazil, and a few other locations that would also benefit from this drug. Ultimately, it's to keep people alive and give them a better chance for future health.
Recent ZEOX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 11:30:33 AM
- ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians • ACCESS Newswire • 04/21/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 11:16:04 AM
- Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (OTCQB:ZEOX) • ACCESS Newswire • 04/09/2026 11:00:00 AM
- ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage • ACCESS Newswire • 04/07/2026 05:56:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 11:50:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 12:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:05:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 08:17:09 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/06/2026 11:54:56 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/29/2026 09:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 11:01:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 10:17:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:05:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2026 09:05:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 01:00:48 PM
- Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States • ACCESS Newswire • 01/07/2026 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 11:02:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 09:05:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2025 12:30:32 PM
- ZEO ScientifiX(TM) Positioned for New Growth as Florida Opens Stem Cell Market • ACCESS Newswire • 10/23/2025 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/15/2025 08:15:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2025 08:05:25 PM
